Evidence map›Paper›PMID 24021346›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2013

Differential effect of soy isoflavones in enhancing high intensity radiotherapy and protecting lung tissue in a pre-clinical model of lung carcinoma.

Gilda G Hillman, Vinita Singh-Gupta, David J Hoogstra, Lisa Abernathy, Joseph Rakowski, Christopher K Yunker, Shoshana E Rothstein, Fazlul H Sarkar, Shirish Gadgeel, Andre A Konski and 2 more

Open access · greenAbstract read
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Radiomitigators: Breakthroughs in Post-Radiation Recovery.Antioxidants (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Isoflavones.Molecules (Basel, Switzerland) · 2019
    Review
  8. Cytokines and radiation-induced pulmonary injuries.Journal of radiation research · 2018
    Review
  9. Occurrence of pneumonitis following radiotherapy of breast cancer - A prospective study.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2018
    Article
  10. Article
  11. Article
  12. Review
  13. Soy Isoflavones Promote Radioprotection of Normal Lung Tissue by Inhibition of Radiation-Induced Activation of Macrophages and Neutrophils.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2015
    Article
  14. Article
  15. Article
  16. Article
  17. Research of Biological Dose Conversion Platform Based on a Modified Linear Quadratic Model.Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Gilda G HillmanDepartment of Radiation Oncology, Wayne State University School of Medicine, Detroit, USA. Electronic address: hillmang@karmanos.org.
Vinita Singh-Gupta
David J Hoogstra
Lisa Abernathy
Joseph Rakowski
Christopher K Yunker
Shoshana E Rothstein
Fazlul H Sarkar
Shirish Gadgeel
Andre A Konski
Fulvio Lonardo
Michael C Joiner
Wayne State University · US

Funding

Soy isoflavones to augment radiotherapy of lung carcinomaR21CA155518 · NCI · WAYNE STATE UNIVERSITY · PI HILLMAN, GILDA G · 2011 to 2012
$347k
NCI NIH HHS 1R21CA155518-01A1NCI NIH HHS R21 CA155518
6 · The paper itself

Abstract

backgroundRadiotherapy of locally-advanced non-small cell lung cancer is limited by radiation-induced pneumonitis and fibrosis. We have further investigated the role of soy isoflavones to improve the effect of a high intensity radiation and reduce lung damage in a pre-clinical lung tumor model.

methodsHuman A549 NSCLC cells were injected i.v. in nude mice to generate a large tumor burden in the lungs. Mice were treated with lung irradiation at 10 Gy and with oral soy. The therapy effect on the tumor cells and surrounding lung tissue was analyzed on lung sections stained with H&E, Ki-67 and Masson's Trichrome. Pneumonitis and vascular damage were evaluated by measurements of alveolar septa and immunofluorescent staining of vessel walls.

resultsCombined soy and radiation caused a significantly stronger inhibition of tumor progression compared to each modality alone in contrast to large invasive tumor nodules seen in control mice. At the same time, soy reduced radiation injury in lung tissue by decreasing pneumonitis, fibrosis and protecting alveolar septa, bronchioles and vessels.

conclusionsThese studies demonstrate a differential effect of soy isoflavones on augmenting tumor destruction induced by radiation while radioprotecting the normal lung tissue and support using soy to alleviate radiotoxicity in lung cancer.

Indexed as

AnimalsCell Line, TumorCytokinesFemaleGlycine maxHumansIsoflavonesLungLung NeoplasmsMiceRadiation PneumonitisRadiation-Protective AgentsRadiation-Sensitizing AgentsCytokinesIsoflavonesRadiation-Protective AgentsRadiation-Sensitizing AgentsLung cancerRadiationSoy isoflavones

Identifiers

PMID24021346
PMCPMC3840154
OpenAlexW2056932288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.